의료 관련 주식
| # | 이전 7일 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1852 |  SLS SELLAS Life Sciences Group, Inc. - Common Stock | 11.34 USD | -4.55% | -0.35% | +0.27% | +422.58% | 2.29 B USD | ||
| 1853 |  PRGO Perrigo Company plc Ordinary Shares | 16.50 USD | +3.38% | +14.11% | +19.48% | -23.33% | 2.29 B USD | ||
| 1859 |  CLDX Celldex Therapeutics, Inc. - Common Stock | 28.93 USD | +3.92% | -0.38% | -26.70% | +6.20% | 2.27 B USD | ||
| 1863 |  MD Pediatrix Medical Group, Inc. Common Stock | 27.75 USD | +2.66% | +4.99% | +6.98% | +73.00% | 2.25 B USD | ||
| 1873 |  HRMY Harmony Biosciences Holdings, Inc. - Common Stock | 38.27 USD | +2.03% | -3.19% | -10.14% | +23.85% | 2.23 B USD | ||
| 1874 |  RXRX Recursion Pharmaceuticals, Inc. - Class A Common Stock | 4.16 USD | +11.23% | +3.74% | +26.44% | -32.36% | 2.23 B USD | ||
| 1875 |  AUPH Aurinia Pharmaceuticals Inc - Common Shares | 16.73 USD | +0.72% | +3.53% | -1.93% | +40.23% | 2.23 B USD | ||
| 1877 |  NEO NeoGenomics, Inc. - Common Stock | 17.25 USD | +2.19% | +7.48% | -9.73% | +71.13% | 2.22 B USD | ||
| 1878 |  VRDN Viridian Therapeutics, Inc. - Common Stock | 19.56 USD | +6.42% | +6.83% | -14.21% | -12.87% | 2.22 B USD | ||
| 1892 |  ADUS Addus HomeCare Corporation - Common Stock | 116.49 USD | -0.11% | +2.33% | -1.59% | -0.03% | 2.18 B USD | ||
| 1893 |  IRON Disc Medicine, Inc. - Common Stock | 56.65 USD | +1.63% | -6.63% | -18.89% | -33.74% | 2.17 B USD | ||
| 1897 |  FTRE Fortrea Holdings Inc. - Common Stock | 22.75 USD | +6.61% | +11.68% | +12.01% | +144.89% | 2.16 B USD | ||
| 1907 |  ASTH Astrana Health Inc. - Common Stock | 38.03 USD | +0.82% | +6.02% | +0.18% | +20.77% | 2.12 B USD | ||
| 1911 |  NVAX Novavax, Inc. - Common Stock | 12.82 USD | +1.42% | +14.77% | +33.26% | +55.96% | 2.11 B USD | ||
| 1914 |  PGNY Progyny, Inc. - Common Stock | 27.46 USD | -1.36% | -0.90% | +0.29% | +40.39% | 2.11 B USD | ||
| 1915 |  VCEL Vericel Corporation - Common Stock | 41.02 USD | +1.91% | +2.96% | +0.98% | +12.85% | 2.10 B USD | ||
| 1918 |  WGS GeneDx Holdings Corp. - Class A Common Stock | 70.22 USD | +2.35% | +2.59% | -29.51% | -40.01% | 2.09 B USD | ||
| 1919 |  BFLY Butterfly Network, Inc. Class A Common Stock | 7.86 USD | +3.42% | -3.44% | +4.52% | +258.90% | 2.09 B USD | ||
| 1929 |  VERA Vera Therapeutics, Inc. - Class A Common Stock | 28.57 USD | +6.84% | -3.38% | -12.09% | -3.93% | 2.06 B USD | ||
| 1930 |  BCRX BioCryst Pharmaceuticals, Inc. - Common Stock | 8.02 USD | -0.37% | -3.02% | -6.09% | +20.24% | 2.05 B USD |
뉴스 의료 관련 주식
UBS, 솔리드 바이오사이언스 투자의견 ‘매수’로 신규 개시···목표주가 20달러 제시
매크로제닉스, 진행성 고형암 환자 대상 비공개 표적 항체-약물 접합체 MGC030의 1상 임상시험에서 첫 환자 투여
목요일 장중 변동한 12개 헬스케어 주식
다이애딕 인터내셔널 13G 공시: 엠퍼리 에셋 매니지먼트, 9월 30일 기준 8.35% 지분 보유 보고
뉴라시스, 의료 정책 적용 범위가 2,600만 명 이상의 의료 보험 가입자에게 확대되었다고 발표
에데사 바이오테크, 백반증 치료제 EB06의 2상 임상시험을 위한 신약 임상시험계획(IND) 신청에 대해 FDA 승인 획득
렉사리아 바이오사이언스, 디하이드라테크-CBD 조성물 및 디하이드라테크-세마글루타이드 모두 평가한 동물실험 GLP-1-A26-1 결과 발표···아쉽게도 뇌 조직 내 DHT-SEMA 농도는 본 연구에 사용된 생물학적 분석의 정량 하한선 이하 수준
Gainers 의료 관련 주식
 ESLA Estrella Immunopharma, Inc. - Common Stock | 0.54 | +68.75% |
 DRMA Dermata Therapeutics, Inc. - Common Stock | 0.91 | +37.88% |
 INDP Indaptus Therapeutics, Inc. - Common Stock | 2.85 | +28.96% |
 HUMA Humacyte, Inc. - Common Stock | 0.44 | +25.71% |
 NMRA Neumora Therapeutics, Inc. - Common Stock | 0.43 | +22.86% |
 PIIIW P3 Health Partners Inc. - Warrant | 0.0072 | +20.00% |
 TRIB Trinity Biotech plc - American Depositary Shares each represent | 7.93 | +19.97% |
 AKTX Akari Therapeutics Plc - American Depositary Shares | 8.67 | +19.75% |
Losers 의료 관련 주식
 SPRC SciSparc Ltd. - Ordinary Shares | 2.00 | -44.75% |
 CDIOW Cardio Diagnostics Holdings Inc. - Warrant | 0.0064 | -28.09% |
 NXGLW NexGel, Inc - Warrant | 0.0065 | -27.78% |
 DRTSW Alpha Tau Medical Ltd. - Warrant | 2.9900 | -17.40% |
 PFSA Profusa, Inc. - Common Stock | 1.07 | -16.41% |
 MDAIW Spectral AI, Inc. - Warrants | 0.4100 | -16.33% |
 CDTTW CDT Equity Inc. - Warrant | 0.0061 | -15.28% |
 PTN Palatin Technologies, Inc. Common Stock | 6.49 | -15.27% |